Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2011 | 0 | 4.700.000 | 236.859 | 1 | ||
2010 | 0 | 1.804.435 | 387.000 | 1 |
Total number of partners: 17
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 17
Frequent / Rare Partner Ratio: 0
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2011-01-01 | Stem Cells for Relevant Efficient Extended and Normalized Toxicology | SCR&TOX | participant | 4.700.000 | 15 |
2010-05-01 | Preclinical study of Recombinant human Anti-C5 for the Treatment of atypical HUS | PRATH | participant | 1.804.435 | 4 |